Loading clinical trials...

Neutrophil to Lymphocyte Ratio and Postdural Headache | Clinical Trials | Clareo Health

RECRUITING

Neutrophil to Lymphocyte Ratio and Postdural Headache

Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictor of Post-Dural Puncture Headache Following Cesarean Section Under Spinal Anesthesia

NCT07075874•Istinye University

View on ClinicalTrials.gov

Summary

This study will aim to investigate whether systemic inflammatory markers-especially the neutrophil-to-lymphocyte ratio (NLR)-obtained from preoperative complete blood counts can predict the development of post-dural puncture headache (PDPH) in obstetric patients undergoing cesarean section under spinal anesthesia.

Eligibility

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Women aged 18 years or older
•Underwent elective or emergency cesarean section under spinal anesthesia
•Had complete preoperative complete blood count (CBC) data available
•No known hematological or inflammatory disease
•No intraoperative complications recorded
•Medical records accessible for postoperative follow-up regarding PDPH symptoms

Exclusion Criteria

•Age under 18
•Absence of preoperative complete blood count data
•Presence of hematologic malignancy, active infection, autoimmune disease, or immunosuppressive therapy
•Platelet count \<150,000/mm³ or INR \>1.5
•Incomplete or missing medical records

Locations (1)

Istinye Üniversity

Istanbul, Merkez Mahallesi, Turkey (Türkiye)

Key Dates

Start Date

July 12, 2025

Primary Completion Date

July 15, 2025

Completion Date

July 17, 2025

Last Updated

July 24, 2025

Enrollment

821

ESTIMATED participants

Conditions

Preoperative Neutrophil-to-Lymphocyte Ratio (NLR)Postdural Puncture Headache

Interventions

PDPH

OTHER

Contacts

ilke dolgun

CONTACT

+905555485632 ilkeser2004@gmail.com

A Prospective Cohort Study to Evaluate the Safety, Efficacy, and Usability of the EpiZact Device

NCT06729255

Postdural Puncture HeadacheEpidural Analgesia, Obstetric

View study

COMPLETEDNA

Postdural Punction Headache After Ceserian Section

NCT05777694

Postdural Puncture HeadacheRegional Anesthesia Morbidity+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 24, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Neutrophil to Lymphocyte Ratio and Postdural Headache

Inclusion Criteria

Exclusion Criteria

A Prospective Cohort Study to Evaluate the Safety, Efficacy, and Usability of the EpiZact Device

Postdural Punction Headache After Ceserian Section

Spenopalatine Ganglion Block for Treatment of Post-dural Puncture Headaches

Chronic Headache and Chronic Backache Following Unintentional Dural Puncture at Delivery Room.

Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department

Role of Prophylaxis by Oral Fluid Supplementation in Prevention of Postdural Puncture Headache